Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018

SELL
$20.4 - $24.6 $324,686 - $391,533
-15,916 Reduced 59.48%
10,843 $249,000
Q2 2018

Aug 14, 2018

BUY
$19.02 - $24.95 $332,583 - $436,275
17,486 Added 188.57%
26,759 $597,000
Q1 2018

May 15, 2018

BUY
$22.55 - $29.9 $119,131 - $157,961
5,283 Added 132.41%
9,273 $212,000
Q4 2017

Feb 14, 2018

BUY
$18.0 - $30.0 $71,820 - $119,700
3,990
3,990 $105,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $115M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.